Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Evidence is emerging that podocytes are able to endocytose proteins such as albumin using kinetics consistent with a receptor-mediated process. To date the role of the fatty acid moiety on albumin uptake kinetics has not been delineated and the receptor responsible for uptake is yet to be identified. Albumin uptake studies were carried out on cultured human podocytes exposed to FITC-labelled human serum albumin either carrying fatty acids (HSA+FA) or depleted of them (
HSA
-FA). Receptor-mediated endocytosis of FITC-HSA+FA over 60 min was 5 times greater than that of FITC-
HSA
-FA. 24h exposure of podocytes to albumin up-regulated nephrin expression and induced the activation of caspase-3. These effects were more pronounced in response to
HSA
-FA. Individually, anti-
CD36
antibodies had no effect upon endocytosis of FITC-
HSA
. However, a cocktail of 2 antibodies reduced uptake by nearly 50%. Albumin endocytosis was enhanced in the presence of the
CD36
specific inhibitor sulfo-N-succinimidyl oleate (SSO) while knock-down of
CD36
using CD36siRNA had no effect on uptake. These data suggest that receptor-mediated endocytosis of albumin by podocytes is regulated by the fatty acid moiety, although, some of the detrimental effects are induced independently of it.
CD36
does not play a direct role in the uptake of albumin.
...
PMID:The effect of albumin on podocytes: the role of the fatty acid moiety and the potential role of CD36 scavenger receptor. 2481 72
The association of unesterified fatty acid (FA) with the scavenger receptor
CD36
has been actively researched, with focuses on FA and oxidized low density lipoprotein (oxLDL) uptake.
CD36
has been shown to bind FA, but this interaction has been poorly characterized to date. To gain new insights into the physiological relevance of binding of FA to
CD36
, we characterized FA binding to the ectodomain of
CD36
by the biophysical method surface plasmon resonance. Five structurally distinct FAs (saturated, monounsaturated (cis and trans), polyunsaturated, and oxidized) were pulsed across surface plasmon resonance channels, generating association and dissociation binding curves. Except for the oxidized FA HODE, all FAs bound to
CD36
, with rapid association and dissociation kinetics similar to
HSA
. Next, to elucidate the role that each FA might play in
CD36
-mediated oxLDL uptake, we used a fluorescent oxLDL (Dii-oxLDL) live cell assay with confocal microscopy imaging.
CD36
-mediated uptake in serum-free medium was very low but greatly increased when serum was present. The addition of exogenous FA in serum-free medium increased oxLDL binding and uptake to levels found with serum and affected
CD36
plasma membrane distribution. Binding/uptake of oxLDL was dependent upon the FA dose, except for docosahexaenoic acid, which exhibited binding to
CD36
but did not activate the uptake of oxLDL. HODE also did not affect oxLDL uptake. High affinity FA binding to
CD36
and the effects of each FA on oxLDL uptake have important implications for protein conformation, binding of other ligands, functional properties of
CD36
, and high plasma FA levels in obesity and type 2 diabetes.
...
PMID:CD36 binds oxidized low density lipoprotein (LDL) in a mechanism dependent upon fatty acid binding. 2555 8